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Abstract
Background: In conjunction with the growing prevalence of obesity and the older age of pregnant women
gestational diabetes (GDM) is a major health problem.
The aim of the study was to evaluate if a lifestyle intervention since early pregnancy is feasible in improving the
glucose tolerance of women at a high-risk for GDM in Finland.
Methods: A 75-g oral glucose tolerance test (OGTT) was performed in early pregnancy (n = 102). Women at high
risk for GDM (n = 54) were randomized at weeks 8-12 from Apr 2005 to May 2006 to a lifestyle intervention group
(n = 27) or to a close follow-up group (n = 27). An OGTT was performed again at weeks 26-28 for the lifestyle
intervention and close follow-up groups.
Results: The values of the OGTT during the second trimester did not differ between the lifestyle intervention and
close follow-up groups. In the lifestyle intervention group three women had GDM in the second trimester and
respectively one woman in the close follow up group. Insulin therapy was not required in both groups. The
intervention resulted in somewhat lower weight gain 11.4 ± 6.0 kg vs. 13.9 ± 5.1 kg, p = 0.062, adjusted by the
prepregnancy weight.
Conclusions: Early intervention with an OGTT and simple lifestyle advice is feasible. A more intensive lifestyle
intervention did not offer additional benefits with respect to glucose tolerance, although it tended to ameliorate
the weight gain.
Trial Registration: ClinicalTrials.gov: NCT01130012
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Background
Management for women with gestational diabetes mellitus
(GDM) consists of dietary counselling and physical exer-
cise, and for those women who fail to maintain glycemic
goals, insulin therapy [1]. Type 2 diabetes can be pre-
vented or delayed by lifestyle changes, including increased
physical activity, improvements in diet and modest weight
loss in high-risk individuals [2,3]. There is little evidence
demonstrating that GDM can be prevented by lifestyle
changes in women at a high risk for GDM. Dempsey et al.
found women most active within the first 20 weeks of
pregnancy were half as likely to develop GDM [4].
GDM is defined as carbohydrate intolerance of varying
severity with onset or first recognition during pregnancy
[5,6]. Type 2 diabetes and GDM have similarities: both
are characterized by a strong family history, overweight,
insulin resistance, and lack of compensatory pancreatic
insulin secretion in demanding hormonal circumstances
[7,8]. GDM is usually diagnosed between 24-28 weeks of
pregnancy [9].
The occurrence of GDM varies from 2.2 to 8.8%
depending on the diagnostic criteria used and popula-
tion studied [10]. Like type 2 diabetes, the prevalence of
GDM is increasing at an alarming rate worldwide [11].
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whom and how to screen for GDM. Like many
other European countries, Finland focuses screening on
high-risk groups in the beginning of the third trimester
26-28 weeks [12-14].
We therefore carried out a randomized controlled trial
in 54 pregnant women at high risk for GDM. We com-
pared the effectiveness of early intensive lifestyle inter-
vention to a single session lifestyle advice combined with
a close follow-up. The hypothesis of this feasibility study
was that early screening with an oral glucose tolerance
test (OGTT) and lifestyle treatment since early pregnancy
can improve glucose tolerance and decrease the inci-
dence of GDM and related perinatal complications.
Methods
The study was an open multicenter randomized and
controlled study with two rural municipalities: Kauha-
joki and Lapua. The recruitment started in April 2005
and ended in May 2006. Deliveries occurred from Nov
2005 to Dec 2006. The protocol was approved by the
ethics committee of South Ostrobothnia Hospital Dis-
trict in Seinäjoki, Finland. It was in accordance with
Helsinki Declaration. All women participating in the
trial gave written informed consent.
The health care nurses gave women counselling about
healthy lifestyle in the beginning of pregnancy. The diet-
ary and exercise advice were provided both verbally and
in writing. Women were advised to stop alcohol intake
and smoking.
Randomisation
A 2-hour OGTT was offered to all women in the first
contact with maternal health care units during gesta-
tional weeks 8-12. If the women had one or more risk
factors (BMI > 25 kg/m
2, previous history of GDM or
birth of child > 4.5 kg, age > 40 years, family history of
diabetes i.e. parents, children, siblings or grandparents)
or the venous plasma glucose concentration after
12 hours fasting in the morning was 4.8-5.5mmol/l and
2-hour OGTT plasma glucose < 7.8mmol/l, they were
recruited to the intervention (Figure 1).
These high-risk women were randomly assigned to the
lifestyle intervention group (n = 27) or to the close fol-
low-up group (n = 27) by the study physician in the
Central Hospital with the use of a computed randomisa-
tion list (Figure 1). We randomized 60 women, three
dropped out (10%) in each group (four early miscar-
riages, one twin pregnancy and one woman moved
away). The health care nurses who scheduled the study
visits did not have access to the randomisation list. We
excluded women (n = 14) who were diagnosed as having
GDM in this study and women who had risk factors for
GDM or whose fasting venous plasma glucose was
4.8-5.5mmol/l but who for personal or professional
reasons did not wish to participate in the trial (n = 28).
Obstetricians who were not study physicians made deci-
sions concerning the beginning of insulin treatment, if
the glucose targets were not achieved (fasting capillary
glucose > 5.8 mmol/l or postprandial capillary glucose >
8.5 mmol/l during self-monitoring, Figure 2).
Diet counselling in the lifestyle intervention group
Based on the general dietary recommendations of the
Diabetes and Nutrition Study Group (DNSG) of Eur-
opean Association for the Study of Diabetes [15] for dia-
betes and the Finnish Diabetes Prevention Study [2], the
goals of the diet in this study were carbohydrate 50-55
energy percent (E%), fibre 15 g/1000 kcal, fat 30 E%,
saturated fat < 10 E% and protein 15-20 E%. Women
were encouraged to eat a diet rich in vegetables, berries
and fruits, and to use low-fat dairy products, low-fat
meat, soft margarines and vegetable oils and whole-
grain products. Recommendation for energy intake was
30 kcal/kg/day for normal weight women and 25 kcal/
kg/day for overweight women.
The nurse in the health care centres had on average 13
appointments with the intervention women. The inter-
vention women had no instruction on self glucose moni-
toring before GDM was diagnosed. The nutritionist gave
dietary advice tailored to each subject individually six
times. The three-factor eating questionnaire was used in
the beginning of pregnancy and at weeks 36-40 [16].
Exercise counselling in the lifestyle intervention group
We encouraged moderate-intensity physical exercise
during pregnancy. The formula (220-age) × 0.65-0.75
was used to estimate the heart rate goals for moderate-
intensity exercise [17]. Other measures of exercise inten-
sity included the “talk test” [18], i.e. exercise at an inten-
sity in which the woman is able to maintain a
conversation during exercise. A target rating of 12 to 14
on Borg’s scale of perceived exertion [19] was also used.
The pregnant women had six appointments with the
physiotherapist. During sessions the physiotherapist
motivated the women individually to continue exercising
during pregnancy or to start exercising, and gave also
written instructions for exercise and self care. When
starting an aerobic exercise program, previously seden-
tary women were instructed to begin with 15 minutes of
continuous exercise three times a week [20], increasing
gradually to 30 minute sessions four times a week [21].
The goal of the exercise intervention was 30 minutes of
daily physical activity, if the woman previously exercised
< 2.5 hours per week, and 45 minutes activity [22], if the
woman already engaged in 2.5 hours or more per week of
physical activity. Recommendable types of exercise were
brisk walking, Nordic walking, swimming, cycling and
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Page 2 of 8cross country skiing [23]. If the BMI of a woman was >
30 kg/m
2 and the woman was not physically active before
pregnancy, the exercise was started with 15 minutes per
day three times a week [20,22]. Women were offered
both aerobics classes and aquafit classes weekly.
Close follow-up group
The women were informed of the results of the OGTT
during gestational weeks 8-12. All women were also
given general information on diet and physical activity
to decrease the risk of GDM during pregnancy. Dietary
information was collected three times during pregnancy.
They returned a self reported exercise history and a
monthly questionnaire of physical activity. Otherwise,
the women were followed up in the prenatal clinic of
the municipal health centre at one-month intervals
according to standard care in Finland (Figure 2) [24].
Definition of GDM
The GDM criteria were modified from the World
Health Organization as a fasting plasma glucose
5.6mmol/l or 2-hour plasma glucose 7.8mmol/l [6].
Early intervention  
n =102 
OGTT
a at weeks 8-12 
Excluded
c Randomisation 
groups A+B  Standard care 
n=60 n = 42 
Lifestyle
intervention 
Close follow-up 
group B
n = 27
b group A n = 27
b
GDM
d 3 (11.1%)  GDM 1 (3.7%)
Insulin treat-  Insulin treat-
ment n=0 ment n=0 
a Oral glucose tolerance test. 
bGroup A and B 30 women in 
the beginning: three dropped out (10%) in each group, four
early miscarriages, one twin pregnancy and one woman  
moved away.
c14 women had GDM in the beginning, 28  
women did not wish to participate in the intervention. 
dGestational diabetes mellitus (fasting plasma glucose 5.6
mmol/l or 2-hour plasma glucose 7.8 mmol/l). 
Figure 1 Formation of the study populations.
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Page 3 of 8Screening for GDM
A 2-hour OGTT containing 75 g glucose was offered to
all women in the early intervention groups during gesta-
tional weeks 8-12 (Table 1). The OGTT was repeated
during gestational weeks 26-28.
Examinations
A nurse measured height, weight, and blood pressure of
women at the first appointment during gestational
weeks 8-12. Blood pressure was measured twice on the
right arm with the subject in a sitting position after
aGestational diabetes mellitus, 
bBody-mass index, 
cOral glucose tolerance test, 
dvenous 
plasma glucose, 
efasting capillary plasma glucose, 
fpost prandial capillary plasma glucose,      
g Maternal care unit 
History of  GDM
a 
Repeated glucosuria 
Macrosomic baby  
Risk factors: 
BMI
b>25 kg/m
2 
Birth of child >4.5 kg 
Age over 40 years 
Family history of diabetes 
Glucosuria 
75 g OGTT
c 
vP-Gluc 4.8-10.0-8.7 
(during pregnancy) 
  75 g OGTT 
  vP-Gluc 4.8-10.0-8.7 
 (weeks 26-28) 
75 g  OGTT 
vP-Gluc 4.8-10.0-8.7 
(week 32) 
Normal 
Follow-up at 
maternal health care 
in municipalities  
GDM diagnosed 
Lifestyle counselling 
Self glucose monitoring  
Normal  One abnormal 
value 
Lifestyle counselling 
Self glucose monitoring 2-3 
days weekly 
Follow-up at MCU
g               
of Central Hospital 
 
2 - 3 values abnormal 
Follow-up every 2-4 
weeks at MCU 
Insulin treatment 
Follow-up every 2-4 
weeks at MCU 
 
fcP - Gluc
e <5.8 
ppcP- Gluc
f<8.5 
fcP-Gluc > 5.8 
ppcP-Gluc  > 8.5 
Figure 2 Screening and follow-up of the gestational diabetes in Finland 2005.
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Page 4 of 810 min of rest, using a standard automatic sphygmo-
manometer. Newborns and placentae were weighed
immediately after delivery. The data of singleton preg-
nancies and deliveries were extracted from the medical
records in maternal health care units and in the Central
Hospital of Seinäjoki.
A 75 g 2-hour oral glucose tolerance test after overnight
fasting for 12 hour was performed at gestational weeks
8-12 and at weeks 26-28 with measurement of plasma glu-
cose at 0, 1 and 2 hours. Plasma glucose was determined
immediately with a photometric hexokinase assay from
samples drawn into a fluoride-citrate tube (Abbot Labora-
tories, Abbot Park IL) in the Central Hospital of Seinäjoki.
Statistical analysis
Statistical analyses were based on the intention to treat.
The final analyses were conducted using SPSS for
Windows version 15.0 (SPSS Inc, Chicago, Illinois). Differ-
ences between the groups were analysed by Student’s
t-test for continuous variables, and the chi-square test and
Fisher’s exact test for categorical variables. Statistical
significance was set at the 95% level (p < 0.05).
Results
Baseline characteristics of the study groups
There were no statistically significant differences in
baseline measures between the lifestyle intervention
(n = 27) and the close follow-up (n = 27) groups
(Table 2).
Glucose tolerance at weeks 26-28
There was no difference between the randomized
groups in the change in glucose values from baseline to
gestational weeks 26-28 during the 2-hour OGTT.
There was also no difference between the randomized
groups in glucose tolerance at weeks 26-28. GDM was
diagnosed in three of the lifestyle intervention group
and in one of the close follow-up group. None of them
required insulin therapy (Table 3).
Maternal outcomes
The intervention resulted in somewhat lower weight
gain during pregnancy (11.4 ± 6.0 kg vs. 13.9 ± 5.1 kg,
p = 0.062, adjusted by the prepregnancy weight).
There was no statistically significant difference
between the randomised groups in terms of pre-eclam-
psia, induction of labor, lacerations, Cesarean deliveries
(data not shown).
Newborn outcomes
The mean birth weight was greater 3871 ± 567 g in
the lifestyle intervention group (p = 0.047, adjusted by
the prepregnancy weight of the women) compared with
the close follow-up group 3491 ± 573 g. The mean birth
weight was 3564 g in the period 1996-2000 in Finland
[25]. There was no difference in macrosomia (p = 0.480,
adjusted by the prepregnancy weight of the women)
between the groups.
There was no statistically significant difference
between the randomized groups in terms of gestational
age, admissions to neonatal intensive care unit, jaundice
requiring phototherapy or respiratory distress (data not
shown).
Discussion
Early intervention with an OGTT and lifestyle advice in
high-risk mothers is feasible. More intensive lifestyle
advice was not more effective than close follow-up.
However, weight gain during pregnancy tended to be
lower in the intensive group. The rate of neonatal com-
plications in the study groups was similar.
Somewhat surprisingly, the intensive lifestyle interven-
tion and the close follow-up were equally effective with
respect to glucose tolerance and GDM in the current
study. High-risk pregnant women may be particularly
receptive to lifestyle advice. On the other hand a part of
w o m e na r en o ta b l et oc h a n g et h e i rl i f e s t y l eo rt h e
maintenance of applied eating or physical activity habits
are short sighted even during pregnancy. Small group
differences at randomization may also have affected the
results. Prepregnancy weight in the lifestyle intervention
Table 1 Research design and methods
Counselling and
follow-up
Lifestyle intervention
(n = 27)
a
Close follow-up
(n = 27)
a
Lifestyle counselling
(nurse)
++
OGTT
b (weeks 8-12) + +
SGM
c --
Diet reporting
d 3 times 3 times
TFEQ
e 2 times 2 times
Counseling(clinical
nutritionist)
6 times -
Exercise history + +
Exercise reporting diaries
monthly
6 times 6 times
Exercise counselling
(physiotherapist)
6 times, twice in
groups
-
OGTT (weeks 26-28) + +
GDM
f-counselling (nurse)
and SGM
++
a60 women randomized in the beginning: three dropped out (10%) in each
group (4 early miscarriages, one twin pregnancy and one woman moved
away).
bOral glucose tolerance test.
cSelf glucose monitoring.
d4-day food records at baseline, at weeks 26-28 and in the end of pregnancy.
eThe three-factor eating questionnaire [16].
fGestational diabetes mellitus.
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Page 5 of 8group tended to be higher compared with the close fol-
low-up group, and all women weighing over 100 kg
were in the intervention group. The women in the close
follow-up group tended to have a higher educational
status (p = 0.080).
Few studies have assessed the role of intervention
early in pregnancy on the prevention or treatment of
GDM. In the study by Bartha et al. women with an
early diagnosis and treatment of gestational diabetes
represented a high-risk group with a worse prognosis
regarding pregnancy complications and outcomes [26].
Callaway recruited 25 obese women at 12 weeks’
gestation in a randomized controlled study. They
received an individualized exercise program with an
energy expenditure (EE) goal of 900 kcal/week. This
intervention was feasible and prompted a modest
increase in physical activity [27]. The study was under-
powered to detect an effect on GDM.
We used GDM criteria modified from the WHO defi-
nition (fasting plasma glucose 5.6mmol/l or 2-hour glu-
cose 7.8mmol/l) [6]. Interestingly, we found 14 cases of
GDM already in the beginning of pregnancy, suggesting
that they had prepregnancy impairment of glucose
metabolism. Treatment for GDM was initiated in early
Table 2 Baseline characteristics of the women (mean ± SD or numbers, percentage in parentheses)
Characteristic Lifestyle intervention
n=2 7
Close follow-up
n=2 7
p value
a
Age 29.1 ± 5.4 29.8 ± 5.4 NS
Primiparous 13 (50) 17 (63) NS
Body-mass index (kg/m
2) 27.3 ± 6.0 25.5 ± 3.4 NS
Prepregnancy weight (kg) 76.6 ± 16.1 69.6 ± 9.7 0.061
Previous Cesarean delivery 3 (12) 1 (3.7) NS
Risk factors 25 (86.2) 21 (72.4) NS
BMI > 25 (kg/m
2) 18 (60) 17 (56.7) NS
Previous birth of child > 4.5 kg 0 1 (3.4) NS
Age > 40 years 0 1 (3.3) NS
Previous history of GDM 5 (16.7) 1 (3.4) NS
Family history of diabetes 13 (43.3) 12 (41.4) NS
Prepregnancy smoking 1 (3.7) 2 (7.4) NS
Higher educational status 5 (18.5) 12 (44.4) 0.080
Office or service work 13 (46.4) 18 (64.3) NS
Fasting glucose (mmol/l) 5.0 ± 0.3 4.9 ± 0.3 NS
OGTT 1-hour glucose (mmol/l) 6.4 ± 1.4 6.0 ± 1.1 NS
OGTT 2-hour glucose (mmol/l) 5.6 ± 1.0 5.4 ± 1.0 NS
Area under the curve (mmol/l/2 h) 11.7 ± 1.7 11.2 ± 1.5 NS
Systolic blood pressure (mmHg) 117.3 ± 10.3 119.4 ± 8.9 NS
Diastolic blood pressure (mmHg) 72.9 ± 7.9 70.9 ± 7.4 NS
ap value: Student’s t-test for independent samples, chi-square or Fisher’s exact test.
Table 3 Weight gain, oral glucose tolerance test at weeks 26-28 and requirement of insulin therapy (mean ± SD or
numbers, percentage in parentheses)
Outcomes Lifestyle intervention group n = 27
a Close follow-up group n = 27 p value
b
Total weight gain (kg) 11.4 ± 6.0 13.9 ± 5.1 NS
Weight at the end of pregnancy ( kg) 88.6 ± 14.4 84.1 ± 11.3 NS
Fasting glucose (mmol/l) 4.6 ± 0.4 4.4 ± 0.3 NS
OGTT 1-hour glucose (mmol/l) 6.9 ± 1.7 6.9 ± 1.7 NS
OGTT 2-hour glucose (mmol/l) 6.1 ± 1.4 6.0 ± 1.2 NS
Area under the curve (mmol/l/2 h) 12.3 ± 2.4 12.1 ± 2.2 NS
Gestational diabetes 3 (11.1) 1 (3.7) NS
Insulin therapy 0 0 NS
aAn OGTT was carried out in 26 (96.3%) women in the lifestyle intervention group.
bp value: Student’s t-test for independent samples or Fisher’s exact test was used.
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Page 6 of 8pregnancy for these women, and four normalized their
glucose tolerance and only three required insulin ther-
apy later in their pregnancy. The prevalence of GDM
was 12.0% (31/258) in study municipalities and at the
same time period in two neighboring municipalities
without early intervention 14.5% (26/181). The differ-
ence was greater concerning the treatment with insulin:
2.3% (6/258) of pregnant women in study municipalities
had insulin treatment compared with 8.3% (15/181) of
women with the standard care. Screening of glucose tol-
erance among high-risk, especially overweight women
and lifestyle advice in early pregnancy may be an effec-
tive way to improve glucose tolerance in high-risk
women in later pregnancy.
When an OGTT is performed very early in the preg-
nancy it is worth noting, that fasting glucose concentra-
tions reach their nadir at 12 weeks of gestation and
remain at this level until delivery [28].
The encouraging finding was that the intervention
resulted in somewhat, albeit not statistically significantly
lower weight gain as compared with the close follow-up
group. However, the prepregnancy weight tended to be
higher (p = 0.061) in the intervention group than in the
close follow-up group. Obese women on average gain less
weight during pregnancy than women with normal weight
[29]. In the analyses, however, we adjusted for prepreg-
nancy weight. In Finland, the mean weight gain during
pregnancy has increased from 13.3 kg in 1960 to 14.3 kg
in 2000 [30]. In the same period the prepregnancy weight
has increased from 57.6 kg to 65.5 kg [30]. In the study
municipalities the prepregnancy weight was 69.1 ± 15.1 kg.
In large cohorts of pregnant women, there has been a
continuous relationship between mother’s glycemia and
newborn birth weight below standard cut-off levels for
GDM [31,32]. Our study group is too small to conclude
from pregnancy outcomes.
One of the strengths of this feasibility study is that it was
performed in a community-based setting in a rural area,
and the intervention was conducted with little or no extra
resources. Although the results of the study were encoura-
ging, there were obvious weaknesses. First, the study had a
relatively small number of participants. Second, the inter-
ventions seemed to be so “effective” that the number of
cases of GDM in the randomized groups of high-risk
women was very small, only four out of 54 women. Third
we had no international consensus of criteria for GDM in
the year 2005. Finnish threshold value, especially the fast-
ing glucose 4.8mmol/l, for the diagnosis of GDM was too
low in early pregnancy. This is the reason why we used
the modified WHO definition for the early intervention
groups. This complicated the study setting. This study was
carried out as a feasibility study. The results should be
viewed against this background and need to be corrobo-
rated in larger studies.
Conclusions
In this community-based intervention study, our find-
ings suggest that early intervention with an OGTT and
simple lifestyle advice is feasible. More intensive lifestyle
intervention does not seem to have marked additional
benefits. Concentration on high-risk, especially over-
weight women may be important and useful. Larger
trials are nonetheless needed.
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